Myelo Therapeutics: Funding, Investors & Team (Sep 2026)
Myelo Therapeutics is focused on the development of treatments for a range of medical needs. It offers myelo001, a molecule that is effective on the hematogenesis. Myelo Therapeutics was founded by Till Erdmann in 2013. It is based in Berlin, Germany.
Myelo Therapeutics has raised $17.4M across 1 funding round on record, the most recent a Grant of $17.4M announced in Aug 2022.
That round is above the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Myelo Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Myelo Therapeutics Funding Rounds
Myelo Therapeutics Founders and Leadership Team
Contact details for the Myelo Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Myelo Therapeutics Funding Compared to Other Health Care Startups
Myelo Therapeutics' latest round of $17.4M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Myelo Therapeutics in Health Care and Berlin
Companies Similar to Myelo Therapeutics
Arab Therapy functions as a startup that focuses on mental health.
Intu Diagnostics develops rapid and instrument-free solutions for infectious disease diagnostics, aiming for…
Maple Aviation is a medical logistics startup that specializes in building and operating autonomous drone…
Regulate is a wellness and performance company that provides science-backed breathwork programs and a mobile…
Avelios is a modular clinic platform that digitizes and optimizes all clinic processes in a user-friendly…
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary…
XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and…
Wellster is the go-to solution for everyday consumer health. It builds digital clinics along the lifecycle of…
Berlin Heals Holding is a developer of implantable medical device for the cure of heart failure.
Recare is reevaluating the process of discharge management by utilizing digital tools to improve…
Altavo operates as a medical device startup. Altavo harness the power of machine learning and…
Prosoma is a medical company creating digital therapeutics products for cancer patients. We develop a…
Myelo Therapeutics Funding FAQs
What does Myelo Therapeutics do?
Myelo Therapeutics is focused on the development of treatments for a range of medical needs. It offers myelo001, a molecule that is effective on the hematogenesis. Myelo Therapeutics was founded by Till Erdmann in 2013. It is based in Berlin, Germany.
How much funding has Myelo Therapeutics raised?
Myelo Therapeutics has raised $17.4M across 1 round on record. The most recent is a Grant of $17.4M announced in Aug 2022.
When did Myelo Therapeutics last raise funding?
Myelo Therapeutics' most recent funding round on record is a Grant of $17.4M, announced in Aug 2022.
Who founded Myelo Therapeutics?
FundedIQ lists Till Erdmann (Founder) at Myelo Therapeutics.
Where is Myelo Therapeutics headquartered?
Myelo Therapeutics is based in Berlin, Germany.
How many employees does Myelo Therapeutics have?
Myelo Therapeutics is in the 1-10 employee band.
How does Myelo Therapeutics' funding compare to other Health Care startups?
Myelo Therapeutics' latest round of $17.4M is above the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Myelo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Myelo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.